Sidley Austin represented ADVANZ PHARMA on the transaction. ADVANZ PHARMA, a Nordic Capital portfolio company, announced the issuance of €917 million (equivalent) in new euro- and…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
